Minal Barve

4PUBLICATIONS
62CO-AUTHORS
Gene and molecular therapyMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jul 25, 2025
Phase 2, Open-Label, Multicenter Study of Nelitolimod in Combination with Pembrolizumab in Anti-PD-1 Treatment-Naïve Advanced Melanoma.

Antoni Ribas, Mohammed M Milhem, Christopher J Hoimes

|Mar 03, 2025
HER2-Selective Tyrosine Kinase Inhibitor, Zongertinib (BI 1810631), in Patients With Advanced/Metastatic Solid Tumors With <i>HER2</i> Alterations: A Phase Ia Dose-Escalation Study.

John V Heymach, Frans Opdam, Minal Barve

|Apr 08, 2024
Efficacy and Safety of Adagrasib plus Cetuximab in Patients with KRASG12C-Mutated Metastatic Colorectal Cancer.

Rona Yaeger, Nataliya V Uboha, Meredith S Pelster

|Jun 20, 2023
A Phase Ib, Open-label Study Evaluating the Safety and Efficacy of Ipatasertib plus Rucaparib in Patients with Metastatic Castration-resistant Prostate Cancer.

David Pook, Daniel M Geynisman, Joan Carles

Pageof 1

Frequent Collaborators

1 joint publications

David Pook

1 joint publications

Daniel M Geynisman

1 joint publications

Joan Carles

1 joint publications

Filippo de Braud